Nigar Afandiyeva

Nigar Afandiyeva

Auto-generated profile, based on publicly available information

Nigar Afandiyeva

Faculty of Medicine, Department of Medical Biochemistry , Gazi University , Ankara , Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Closed access
FAFeride Ayyıldız
Feride Ayyıldız
HYHİLAL YILDIRAN
HİLAL YILDIRAN
NANigar Afandiyeva
Nigar Afandiyeva
ÖGÖzlem Gülbahar
Özlem Gülbahar
OKOğuz Köktürk
Oğuz Köktürk
The aim of this study was to investigate the effect of vitamin D on the disease prognosis and biochemical parameters in patients with mild obstructive sleep apnea syndrome(OSAS). Nineteen adult male individuals(18-65 years) who were diagnosed with mild OSAS after polysomnography and had low vitamin D levels were included in the study. Each week, patients took 50.000 IU Vitamin D3 supplementation for 8 weeks. Polysomnography, biochemical parameters FBG (fasting blood glucose), lipid profile (TG, TC, LDL-C, HDL-C, VLDL-C), calcium, phosphorus, parathormone, calcitonin, serum 25(OH)D, insulin, CRP, TNF-?, IL-6 and IL-10 of patients were evaluated at the beginning of study and at the end of the study. All assessments, including polysomnography, were repeated after 8 weeks. Serum vitamin D levels were initially 19.5 ± 5.01 ng / mL and increased to 41.8 ± 10.51 ng / mL (p <0.001) at the end of the study. FBG, TC and HOMA-IR of the patients were significantly decreased (p <0.05). CRP,TNF-?, IL-6 and IL-10 levels were also correlated with serum vitamin D levels (p <0.05). There was a significant decrease in number of obstructive apneas, apneas and hypopneas, apnea index, hypopnea index and apnea hypopnea index of the patients (p <0.05). As a result, it is thought that vitamin D supplementation may have a positive effect on the disease prognosis of mild OSAS.

16 November 2023 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
NYNiyazi Samet Yilmaz
Niyazi Samet Yilmaz
BŞBayram Şen
Bayram Şen
BABurak Arslan
Burak Arslan
TBTuba Saadet Deveci Bulut
Tuba Saadet Deveci Bulut
BNBelkis Narli
Belkis Narli
OGOzlem Gulbahar
Ozlem Gulbahar
Objectives: Autoverification (AV) is releasing laboratory results using predefined rules. AV standardizes the verification of laboratory results, improves turnaround time (TAT), detects errors in the total test process, and enables effective use of laboratory staff. In this study, we aimed to evaluate the outcomes of implementing the AV in a tertiary hospital. Methods: The study was performed in Gazi University Health Research and Application Hospital, Core Biochemistry Laboratory, between August 2017 and October 2019. Step by step, AV algorithms were designed and implemented via middleware for 29 clinical biochemistry tests. A comprehensive validation was performed before the AV system was run. Initially, AV system was tested with datasets and simulated patients (dry testing). Next, samples that may violate AV rules were tested anonymously with no-named trial barcodes (wet testing). Finally, validation of the system was performed with real patients, while the AV was running in the background but not active (i.e., while the manual verification was still going on). After all these steps were successful, the system was started. Results: In the daytime, AV rates were ≥75 % for 23 of 29 tests. In night-shift, AV rates were ≥70 % for 16 of 25 tests. Report-based performance was found 26 % for daytime. TAT in the daytime decreased after AV implementation. Conclusions: Although this is the first time we have implemented the AV, a significant percentage of the tests have been verified. However, approaches that will increase the percentage of report-based verification will enhance the efficiency of autoverification.